Strong Buy Rating for Black Diamond Therapeutics Driven by Financial Stability and Promising Clinical Developments
Analyst Robert Burns of H.C. Wainwright reiterated a Buy rating on Black Diamond Therapeutics (BDTX – Research Report), retaining the ...
BBC2y
The Enigma: Mysterious black diamond up for auction
The 555.55 carat black diamond has belonged to its current owner for two decades but little is known about its history before that. A billion-year-old black diamond, believed to be the largest cut ...
Promising Clinical Outcomes and Financial Stability Support Buy Rating for Black Diamond Therapeutics
TD Cowen analyst Marc Frahm has maintained their bullish stance on BDTX stock, giving a Buy rating today. Marc Frahm’s rating is based ...